LEN-B
Lennar Corporation
LEN-B trails on the overall score without a compensating advantage in the available component scores.
NIO
NIO Inc.
NIO has the edge over LEN-B overall, supported by stronger fundamentals and stronger valuation.
LEN-B Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
LEN-B's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
LEN-B PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.4x | $28.56 | -65% |
| Fair | 8.2x | $43.53 | -47% |
| Expensive | 11x | $57.92 | -29% |
| Current | 15x | $81.63 | — |
| Forward | 18x | $81.63 | — |
Historical ranges are pointers, not guarantees.
LEN-B's PE is in its expensive range at 15x. Analysts expect earnings to fall, which would put today's price at 18x next year's earnings.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
LEN-B Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect LEN-B's earnings and profitability to decline, with its revenue holding steady.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over LEN-B on the outlook, with more favorable earnings and revenue expectations.
LEN-B Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.59 | -13% |
| Q3 2026 | $5.28 | -48% |
| Q2 2026 | $6.38 | -47% |
| Q1 2026 | $6.95 | -49% |
| Q4 2025 | $7.98 | -44% |
| Q3 2025 | $10.09 | -33% |
| Q2 2025 | $12.06 | -18% |
| Q1 2025 | $13.70 | -3.8% |
| Q4 2024 | $14.31 | +4.2% |
LEN-B has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
LEN-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | -8.7% |
| Q2 2026 | $7.9B | -5.2% |
| Q1 2026 | $6.6B | -13% |
| Q4 2025 | $9.4B | -5.8% |
| Q3 2025 | $8.8B | -6.4% |
| Q2 2025 | $8.4B | -4.4% |
| Q1 2025 | $7.6B | +4.4% |
| Q4 2024 | $9.9B | -9.3% |
LEN-B's revenue has slid since its 2023 peak: $8B last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -2.2 points |
| Q2 2026 | 5% | -2.5 points |
| Q1 2026 | 3.3% | -5.8 points |
| Q4 2025 | 6.9% | -7.8 points |
| Q3 2025 | 7.9% | -5.7 points |
| Q2 2025 | 7.5% | -6.4 points |
| Q1 2025 | 9.1% | -3.2 points |
| Q4 2024 | 15% | -1.6 points |
LEN-B has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over LEN-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
LEN-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$96.3M | +$94.5M |
| Q2 2026 | -$303.2M | +$807M |
| Q1 2026 | -$463.5M | -$118.4M |
| Q4 2025 | $1.7B | +79% |
| Q3 2025 | -$190.8M | -124% |
| Q2 2025 | -$1.1B | -647% |
| Q1 2025 | -$345.1M | -217% |
| Q4 2024 | $933.1M | -63% |
LEN-B's free cash flow has turned positive again: $811M over the past year, against −$713M the year before.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over LEN-B on cash flow, with more consistent year-over-year improvement.
LEN-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
LEN-B has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LEN-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.1 | Neutral |
| Stochastic | 70.3 | Neutral |
LEN-B's weekly RSI is 46 (neutral) and its Stochastic is 70 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
LEN-B PE vs Consumer Cyclical Sector
| Metric | LEN-B | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 14% below |
| PE % | 99 | 47 | 52 pts above |
LEN-B is trading at 15x earnings, a 14% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
LEN-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.3 | 0.4% above |
| 20 week MA | $82.1 | 0.6% below |
| 50 week MA | $90.3 | 9.6% below |
| 100 week MA | $102.9 | 21% below |
| 200 week MA | $115.3 | 29% below |
LEN-B has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
LEN-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.9 | $64.4 | +44% |
| 2021 | $64.4 | $91.9 | +43% |
| 2022 | $91.9 | $75.1 | -18% |
| 2023 | $75.1 | $134.1 | +78% |
| 2024 | $134.1 | $133.3 | -0.6% |
| 2025 | $133.3 | $97.4 | -27% |
| 2026 YTD | $97.4 | $81.6 | -16% |
LEN-B has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.